Delèvaux I, André M, Tridon A, Aumaître O
Service de médecine interne, CHU, hôpital Gabriel-Montpied, BP 69, 63003 Clermont-Ferrand, France.
Rev Med Interne. 2001 Mar;22(3):232-7. doi: 10.1016/s0248-8663(00)00323-4.
Chronic urticaria is a common skin disorder. The cause is rarely determined. Autoimmune diseases, particularly autoimmune thyroiditis, have been implicated in the occurrence of chronic urticaria.
We reviewed clinical records of patients with Hashimoto's disease and chronic urticaria.
In our department, six patients had presented chronic urticaria associated with Hashimoto's thyroiditis: four patients, of which three treated with L-thyroxine were euthyroid, the other two were hypothyroid. Hashimoto's thyroiditis had been diagnosed for three patients during the investigation of chronic urticaria. Three patients developed chronic urticaria though they were treated with thyroid suppression for Hashimoto's disease. Two of them had a dramatic improvement with opotherapy. One patient who was euthyroid without treatment improved with hormonal therapy. The fourth patient had a partial remission with thyroid hormones and was cured with corticotherapy.
The mechanism by which thyroid autoimmunity is associated with urticaria is poorly understood. A cross-linking of IgE receptors of mastocytes induced by antithyroid antibodies may be a cause of histamine release. Hormonal therapy may be a potent event for the clinical improvement by the suppression of chronic thyroid stimulation. Assay of thyroid hormone and antithyroid antibodies should be performed in patients with chronic urticaria. Discovery of Hashimoto's thyroiditis with chronic urticaria requires thyroid hormone replacement not only in hypothyroid but also euthyroid patients.
慢性荨麻疹是一种常见的皮肤疾病。其病因很少能确定。自身免疫性疾病,尤其是自身免疫性甲状腺炎,被认为与慢性荨麻疹的发生有关。
我们回顾了桥本氏病和慢性荨麻疹患者的临床记录。
在我们科室,有6例患者出现了与桥本氏甲状腺炎相关的慢性荨麻疹:4例患者,其中3例接受左甲状腺素治疗后甲状腺功能正常,另外2例甲状腺功能减退。在慢性荨麻疹调查期间,3例患者被诊断出患有桥本氏甲状腺炎。3例患者尽管因桥本氏病接受了甲状腺抑制治疗,但仍患上了慢性荨麻疹。其中2例采用对症治疗后有显著改善。1例未经治疗甲状腺功能正常的患者经激素治疗后病情改善。第4例患者经甲状腺激素治疗后部分缓解,经皮质激素治疗后治愈。
甲状腺自身免疫与荨麻疹相关的机制尚不清楚。抗甲状腺抗体诱导肥大细胞的IgE受体交联可能是组胺释放的原因。激素治疗可能通过抑制慢性甲状腺刺激而成为临床改善的有效手段。慢性荨麻疹患者应进行甲状腺激素和抗甲状腺抗体检测。发现患有慢性荨麻疹的桥本氏甲状腺炎患者,不仅甲状腺功能减退的患者需要甲状腺激素替代治疗,甲状腺功能正常的患者也需要。